Clinical, epidemiological and evolution of severe nosocomial pneumonia in intensive care unit
DOI:
https://doi.org/10.24265/horizmed.2016.v16n1.02Keywords:
Hospital-acquired pneumonia, Ventilator-associated pneumonia, Healthcare-associated pneumoniaAbstract
Objective: To describe the clinical and epidemiological characteristics, evolution and to identify mortality factors associated in patients with SNP. Material and Methods: Descriptive study of a serie of cases of the Intensive Care Unit (ICU) of a General Hospital. Medical records of patients which received medical attention and who meet the selection criteria were reviewed. Results: Forty-one clinical records were evaluated. The average age was 69 old, predominantly male (68,3%). SNP was the reason of admission in 60.9% and 95.1% required mechanical ventilation. Hospital stay prior to diagnosis was 10 days, 65% of patients had some risk factor for multi resistence organisms, CPIS of entry was 9.3, cultures were positive in 39% of the cases and of these, 48.8% received proper antibiotic according to culture results. The days of stay in ICU were 20.6 days and 20 of the 41 medical records were for death patients. The clinical and epidemiological characteristics were similar between death and alive patients. An analysis of factors that could be associated with mortality SNP was made and it was found that for an age ≥ 70 years, the presence of any risk factor for multidrug resistence organism and control CPIS ≥ 6 were associated with higher mortality; while acquisition of the ICU was associated to lower mortality. Conclusions: The clinical, epidemiological characteristics and evolution of patients with SNP in our ICU were similar to those describe in the literature. Three factors associated with mortality in the ICU were identified.
Downloads
References
American Thoracic Society. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171: 388-416.
Niederman MS.Guidelines for the management of respiratory infection: why do we need them, how should they be developed,and can they be useful? Curr Opin Pulm Med 1996;2:161-5.
Craven DE, Kunches LM, Kilinsky V, Lichtenberg DA, Make BJ, McCabe WR. Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation. Am Rev Respir Dis 1986; 133:792–796.
Tablan OC, Anderson LJ, Besser R, Bridges C, Hajjeh R, Healthcare Infection Control Practices Advisory Committee, Centers for Disease Control and Prevention. Guidelines for preventing health-care–associated pneumonia, 2003: recommendations of the CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep 2004;53(RR-3):1–36.
Hutt E, Kramer AM. Evidence-based guidelines for management of nursing home-acquired pneumonia. J Fam Pract 2002;51:709–716.
Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002;165:867–903.
Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in medical ICUs in the United States: National Nosocomial Infections Surveillance System. Crit Care Med 1999;27:887–892.
Eggimann P, Hugonnet S, Sax H, Touveneau S, Chevrolet JC, Pittet D. Ventilator-associated pneumonia: caveats for benchmarking. Intensive Care Med 2003;29:2086–2089.
Leroy O, Jaffré S, d´Escrivan T, Devos P, Georges H, Alfandari S. Hospital-Acquired Pneumonia. Risk factors for antimicrobial-resistant causative pathogens in critically ill patients. Chest 2003;123:2034-2042.
Soo Hoo G, Wen E, Nguyen T, Bidwell Gotees M. Impact of clinical guidelines in the management of severe HospitalAcquired Pneumonia. Chest 2005;128:2778-2787.
Lee S, Hua C, Yu T, Shieh W, See L. Risk factors of mortality for nosocomial pneumonia: importante of inicial anti-microbial therapy. Int J Clin Pract 2005;2005:39-45.
Luna C, Aruj P, Niederman M, Garzon J, Violi D, Prignoni A et al. Appropiateness and delay to initiate therapy in ventilador-associated pneumonia. Eur Respir J 2006;27:158- 164.
Heyland DK, Cook DJ, Griffith L, Keenan SP, Brun-Buisson C, Canadian Critical Trials Group. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. Am J Respir Crit Care Med 1999;159:1249–1256.
Iregui M, Ward S, Sherman G, Fraser VJ, Kollef MH. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 2002;122:262–268.
Micek S, Ward S, Fraser V, Kollef M. A randomized controlled trial o fan antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia. Chest 2004;125:1791-1799.
Kollef M, Morrow L, Niederman M, Leeper K, Anzueto A, BenzScott L et al. Clinical characteristics and treatment patterns among patients with ventilator-associated pneumonia. Chest 2006;129:1210-1218.
Kollef M, Shorr A, Tabak Y, Gupta V, Liu L, Johannes R. Epidemiology and outcomes of health-care-associated pneumonia. Results from a large US database of culturepositive pneumonia. Chest 2005; 128: 3854 – 3862.
Ruiz M, Guerrero J, Romero C. Etiología de la neumonía asociada a ventilación mecánica en un hospital clínico. Asociación con comorbilidad, uso previo de antimicrobianos y mortalidad. Rev Chil Infect 2007;24(2):131-136.
Celis R, Torres A, Gatell JM, Almela M, Rodriguez-Roisin R, Agusti-Vivaldi A. Nosocomial pneumonia.A multivariate analysis of risk and prognosis.Chest 1988;93(2):318-324.
Luna C, Monteverde A, Rodríguez A, Apezteguía C, Zabert G, Ilutovich S, et al. Neumonía Intrahospitalaria: guía clínica aplicable a Latinoamérica preparada en común por diferentes especialistas. Arch Bronconeumol 2005;41:439–456.
Arancibia F, Ruiz M. Neumonía asociada a ventilación mecánica: Enfoque actual. Rev Chil Med Intensiva 2004;19(2):63-72.
Illodo O, Cristo V, Silva S, Gutierrez L, Fundora E, Cruz C. Factores de riesgo relacionados con la mortalidad en la neumonía asociada la ventilación.Rev Cub Med Int Emerg 2003;2:69-75.
Rotstein C, Evans G, Born A, Grossman R, Light B, Magder S et al. Clinical practice guidelines for hospital-acquired pneumonia and ventilator-associated pneumonia in adults. Can J Infect Dis Med Microbiol 2008;19(1):19-53.
Luna CM, Blanzaco D, Niederman MS, Matarucco W, Baredes NC, Desmery P, Palizas F, Menga G, Rios F, Apezteguia C. Resolution of ventilator-associated pneumonia: prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome. Crit Care Med 2003;31:676–682.
Koening S, Truwitt J. Ventilator-associated pneumonia: diagnosis, treatment and prevention. Clin Microb Rev 2006;19(4):637-657.
Dennesen PJ, Van der Ven AJ, Kessels AG, Ramsay G, Bonten MJ. Resolution of infectious parameters after antimicrobial therapy in patients with ventilator-associated pneumonia. Am J Respir Crit Care Med 2001;163:1371–1375.
Torres A, Aznar R, Gatell JM, Jimenez P, Gonzalez J, Ferrer A et al. Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am Rev Respir Dis 1990;142(3):523-528.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2016 Horizonte Médico (Lima)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Horizonte Médico (Lima) (Horiz. Med.) journal’s research outputs are published free of charge and are freely available to download under the open access model, aimed at disseminating works and experiences developed in biomedical and public health areas, both nationally and internationally, and promoting research in the different fields of human medicine. All manuscripts accepted and published in the journal are distributed free of charge under the terms of a Creative Commons license – Attribution 4.0 International (CC BY 4.0).
